WS #10070

23:56→00:22 UTC
From 495 msgs · 4 key-dev

Biogen acquires RayThera for up to $1B to expand immunology pipeline, lead asset entering Phase 1 in Q3 2026.

Biogen Acquires RayThera

Biogen acquires RayThera for up to $1B to expand immunology pipeline, lead asset entering Phase 1 in Q3 2026.

Full world state #10070 →

US-Iran Peace Deal SignedFed Hawkish Hold
← WS #10069WS #10071 →
BearishNegativeNeutralPositiveBullish|ORDER: SIZE ▾↻ RESHUFFLE▸ LATER / NOW|